Collectively, these results demonstrate that chronic tsRNA-Glu-CTC ASO treatment can ameliorate diet-induced hypercholesterolemia and atherosclerosis in Ldlr-/- mice. The gene discussed is LDLR; the disease is atherosclerosis.